1. Home
  2. ABSI

as 10-06-2025 12:30pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Founded: 2011 Country:
United States
United States
Employees: N/A City: VANCOUVER
Market Cap: 505.4M IPO Year: 2021
Target Price: $7.98 AVG Volume (30 days): 5.8M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.94 EPS Growth: N/A
52 Week Low/High: $2.01 - $6.33 Next Earning Date: 11-11-2025
Revenue: $4,138,000 Revenue Growth: 27.32%
Revenue Growth (this year): 41.73% Revenue Growth (next year): 384.22%

ABSI Daily Stock ML Predictions

Stock Insider Trading Activity of Absci Corporation (ABSI)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Bedrick Todd ABSI SVP, CAO Sep 22 '25 Buy $2.70 10,000 $27,000.00 180,428
Pangalos Menelas N ABSI Director Sep 22 '25 Buy $2.66 95,785 $254,788.10 113,960

Share on Social Networks: